Anesthesia-assisted opiate detoxification

International Anesthesiology Clinics

Volumn 41, Issue 2, 2003, Pages 79-93

  Gevirtz, Clifford ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DIAMORPHINE; FAMOTIDINE; METHADONE; MU OPIATE RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; ONDANSETRON; OPIATE; OPIATE AGONIST;

ABDOMINAL CRAMP; ANESTHESIA; BACKACHE; DIAPHORESIS; DIARRHEA; DRUG DEPENDENCE; DRUG DETOXIFICATION; EMERGENCY TREATMENT; HEALTH PROGRAM; HEALTH VISITOR; HOSPITAL; HUMAN; HYPERTENSION; MYALGIA; NAUSEA; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; VOMITING; WITHDRAWAL SYNDROME;

EID: 0037365415     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200341020-00010     Document Type: Review

References (44)

1. Pulse Check: National Trends in Drug Abuse, Office of National Drug Control Policy, Summer 1998, page 3
2. Drug Facts. Office of National Drug Control Policy, Estimation of Heroin Availability, December 2000, page 14
3. Treatment Episode Data Set (TEDS): 1993-1998. National Admissions to Substance Abuse Treatment. Table 2.1 Drug and Alcohol Services Information System Series: S-11 Sept 2000. Office of Applied Studies. Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
4. Annual Medical Examiner Data 1999, Drug Abuse Warning Network. Table 3.01, page 14, Substance Abuse and Mental Health Services
5. Presslich O, Loimer N. Opiate detoxification under general anesthesia by large doses of naloxone. J Toxicol Clin Toxicol 1989;27:263-270
6. Loimer N, Schmid R, Greenberger J. Acute blocking of naloxone precipitated opiate withdrawal symptoms by methahexitone. Br J Psychiatry 1990;157:748-752
7. Seoane A, Carrasco G, Cabre L. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previouslytreated without success. Br J Psychiatry 1997;171:340-345
8. Mayor S. Specialists criticize treatment for heroin addiction. Br Med J 1997;314:1365
9. American Society of Addiction Medicine. Public Policy Statement on Opioid Antagonist Detoxification under Sedation or Anesthesia (OADUSA), April 2000
10. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998;279:229-234
11. Simon DL. Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art. J Addict Dis 1997;16:103-122
12. Rasmussen K, Beitner-Johnson DB, Krystal JH, et al. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological and biochemical correlates. J Neurosci 1990; 10:2308-2317
13. Albanese AP, Gevirtz CM, Oppenheim B, et al. Outcome and six-month follow-up of patients after UltraRapid Opiate Detoxification (UROD). J Addict Dis 2000;19:11-28
14. Gold CG, Cullen DJ, Gonzales S, et al. Rapid opioid detoxification during general anesthesia. Anesthesiology 1999;91:1639-1647
15. Legarda JJ, Gossup M. A 24-hour inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug Alcohol Depend 1994;35:91-93
16. Lorenzi P, Marsili M, Boncinelli S, et al. Searching for a general anesthetic protocol for rapid detoxification from opioids. Eur J Anaesthesiol 1999;16:719-727
17. Gold MS, Redmond DE Jr, Kleber HD. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry 1979;136:100-102
18. Gold MS. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone and buprenorphine. Psychiatr Clin North Am 1993;16:61-73
19. Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 1997;86:331-345
20. Dolasetron. USP DI Apr '98. Rockville, MD: US Pharmacopeia, page 669
21. Gevirtz C, Frost EAM. Ultrarapid opiate detoxification - current concepts. Curr Opin Clin Exp Res 2000;2:151-167
22. rd ed. Montvale, NJ: Medical Economics Company, 1999, page 2644
23. Hoffman WE, Berkowitz R, McDonald T, et al. Ultrarapid opioid detoxification increases spontaneous ventilation. J Clin Anesth 1998;10:372-376
24. Gold CG, Cullen DJ, Gonzales S, et al. Rapid opioid detoxification during general anesthesia. Anesthesiology 1999;91:1639-1647
25. Kienbaum P, Thurauf N, Michel M, et al. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after μ-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 1998;88:1154-1161
26. Kienbaum P, Scherbaum N, Thurauf N, et al. Acute detoxification of opioid-addicted patients using naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns. Crit Care Med 2000;28:969-976
27. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 1981;32:337-362
28. Gevirtz C, Subhedar DV, Choi CS. Catecholamine surge in opioid-addicted patients in detoxification under general anesthesia. Anesthesiology 1999;90:334-335
29. Berkowitz R, McDonald T, Hoffman W. Narcotic detoxification index used to measure the progress of opioid receptor reversal. Anesth Analg 2000;90:S242
30. McDonald T, Hoffman WE, Berkowitz R, et al. Heart rate variability and plasma catecholamines during opioid detoxification. J Neurosurg Anesthesiol 1999;11:195-199
31. rd ed. Montvale, NJ: Medical Economics Company, 1999, page 1259
32. Gooberman LL, Brewer C. Patent 5789411, U.S. Patent Office, Aug. 4, 1998
33. Simon DL. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Conn Med 1996;60:683-685
34. Gevirtz CM, Frost EAM, Ghodsian M. Analysis of seven deaths associated with ultrarapid opiate detoxification, an example of CRNA-mortality. Anesthesiology (in press)
35. Dyer C. Addict died after rapid opiate detoxification. Br Med J 1998;316:167-172
36. Scherbaum N, Klein S, Kaube H, et al. Alternative strategies of opiate detoxification: evaluation of the so-called rapid detoxification. Pharmacopsychiatry 1998;31:205-209
37. Gevirtz C, Frost EAM. Ultrarapid opiate detoxification: current concepts. Curr Opin Clin Exp Res 2000;2:1-18
38. Patenting of Medical Procedures: Current Opinions of the Council on Ethical and Judicial Policy. American Medical Association, E-9.095, June 1996
39. Simon DL. US Patent 5919760. US Patent Office, July 6, 1999
40. Simon DL. US Patent 5922705. US Patent Office, July 13, 1999
41. Simon DL. US Patent 6087356. US Patent Office, July 11, 2000
42. Gooberman L, Brewer C. US Patent 5789411. US Patent Office, August 4, 1998
43. Legarda Ibanez JJ. US Patent 6103734. US Patent Office, August 15, 2000
44. 42CFR Part 1001